Clinical Trial Update: The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/Phase 2 study of iSCLife-HF, a human umbilical cord mesenchymal stem cell therapy for heart failure, sponsored by Sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• iSCLife-HF

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Heart Failure | Phase 1, Phase 2 | Status: SUSPENDED